These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3179226)

  • 1. Plasma levels of highly sulphated glycosaminoglycans are raised in patients with chronic myeloid leukaemia.
    Craig JI; Reilly KM; Yap PL; Dawes J; Allen L; Parker AC
    Br J Haematol; 1988 Sep; 70(1):27-9. PubMed ID: 3179226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.
    Agis H; Krauth MT; Mosberger I; Müllauer L; Simonitsch-Klupp I; Schwartz LB; Printz D; Böhm A; Fritsch G; Horny HP; Valent P
    J Clin Pathol; 2006 Apr; 59(4):396-402. PubMed ID: 16461568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group.
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick H; Sultan C; Cox C
    Br J Haematol; 1994 Aug; 87(4):746-54. PubMed ID: 7986717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between interleukin-3-like activity and basophil production in chronic myeloid leukemia patients.
    Fishman P; Sredni B; Djaldetti M
    Immunol Lett; 1991 Apr; 28(1):73-7. PubMed ID: 2071173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials.
    Ogasawara A; Matsushita H; Tanaka Y; Shirasugi Y; Ando K; Asai S; Miyachi H
    Clin Chim Acta; 2019 Feb; 489():249-253. PubMed ID: 30165034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic oscillations of leucocyte counts in chronic myeloid leukaemia.
    Malhotra OP; Salam SR
    Postgrad Med J; 1991 Jan; 67(783):87-9. PubMed ID: 2057439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic myeloid leukemia beginning as thrombocythemia. Analysis of 5 cases].
    Cervantes F; Alcorta I; Bosch F; Vives-Corrons JL; Rozman C
    Sangre (Barc); 1992 Feb; 37(1):1-3. PubMed ID: 1585231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of studies of the glycosaminoglycans in the peripheral blood leukocytes of patients in the diagnosis of the phases of chronic myeloleukemia].
    Kharchenko MF; Bessmel'tsev SS; Rukavitsyn OA; Abdulkadyrov KM; Bitiukova ES; Blinov MN
    Ter Arkh; 1997; 69(7):21-6. PubMed ID: 9424753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukaemia: evidence for basophil differentiation and histamine synthesis from cultured peripheral blood cells.
    Denburg JA; Wilson WE; Goodacre R; Bienenstock J
    Br J Haematol; 1980 May; 45(1):13-21. PubMed ID: 6929704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased basophils in peripheral blood: an underutilized criterion for the early diagnosis of chronic myelogenous leukemia.
    La Gioia A
    Scand J Clin Lab Invest; 2020 Oct; 80(6):452-453. PubMed ID: 32525415
    [No Abstract]   [Full Text] [Related]  

  • 11. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia.
    Galton DA
    Leuk Lymphoma; 1992 Aug; 7(5-6):343-50. PubMed ID: 1493435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.
    Meyer B; Krisponeit D; Junghanss C; Murua Escobar H; Bullerdiek J
    Leuk Lymphoma; 2007 Oct; 48(10):2008-13. PubMed ID: 17917968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting chronic leukaemias from assessment of complete peripheral blood counts.
    Hayran M; Koca E; Haznedaroglu IC; Unsal I; Durgun B; Guvenc F; Ozturk B; Ratip S; Ozcebe OI
    J Int Med Res; 2006; 34(6):640-7. PubMed ID: 17294996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia.
    Ma W; Tseng R; Gorre M; Jilani I; Keating M; Kantarjian H; Cortes J; O'Brien S; Giles F; Albitar M
    Haematologica; 2007 Feb; 92(2):170-5. PubMed ID: 17296565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to glycosaminoglycans and cardiolipin in patients with chronic myeloid leukaemia.
    Cheng HM; Sam CK
    Br J Haematol; 1989 Aug; 72(4):594. PubMed ID: 2775663
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia.
    Satoh Y; Masuda A; Jona M; Nannya Y; Yokota H; Kurokawa M; Yatomi Y
    Eur J Haematol; 2014; 92(5):456-7. PubMed ID: 24373003
    [No Abstract]   [Full Text] [Related]  

  • 17. Periodic chronic myelogenous leukaemia: spectral analysis of blood cell counts and aetiological implications.
    Fortin P; Mackey MC
    Br J Haematol; 1999 Feb; 104(2):336-45. PubMed ID: 10050717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated white blood cell synthesis of leukotriene C4 in chronic myelogenous leukaemia but not in polycythaemia vera.
    Stenke L; Samuelsson J; Palmblad J; Dabrowski L; Reizenstein P; Lindgren JA
    Br J Haematol; 1990 Mar; 74(3):257-63. PubMed ID: 2110464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils and basophils carry the fused BCR/ABL gene in chronic myelogenous leukemia: direct fluorescence in situ hybridization analysis on blood smears.
    Lee W; Kim Y; Han K
    Acta Haematol; 1998; 100(2):106-9. PubMed ID: 9792946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Certain biochemical features of leukocytes in blast crisis of chronic myelogenous leukemia].
    Kharchenko MF; Rybakova LP; Filanovskaia LI; Saltykova LB; Bitiukova ES; Shcherbakova EG; Rukavitsyn OA; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MM
    Vopr Med Khim; 1998; 44(3):274-80. PubMed ID: 9703628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.